Mortality due to rheumatic heart disease in the Kimberley 20012010

Insights

Rheumatic heart disease (RHD) causes significant premature mortality in the Kimberley, particularly among Aboriginal people. The age-standardised death rate for RHD in Aboriginal individuals is 1.6 times the national Indigenous Australian rate.

Area of Science:

  • Public Health
  • Cardiology
  • Epidemiology

Background:

  • Rheumatic heart disease (RHD) remains a significant public health concern, especially in remote Australian communities.
  • High mortality rates associated with RHD disproportionately affect Indigenous populations.

Purpose of the Study:

  • To quantify the mortality burden of RHD in the Kimberley region.
  • To assess RHD-related deaths among Aboriginal people in the Kimberley.

Main Methods:

  • Retrospective audit of medical records for deceased patients identified by the Western Australian RHD Program (2001-2010).
  • Inclusion criteria: documented or strongly suggested RHD.
  • Calculation of crude and age-standardised death rates.

Main Results:

  • 34 patients identified with RHD; 15 died from RHD-attributable causes.
  • 93% of RHD deaths were among Aboriginal individuals.
  • Mean age at death for Aboriginal people was 41 years; age-standardised RHD death rate was 12.5 per 100,000 annually (1.6x national Indigenous rate).
  • RHD contributed to 342 potential years of life lost.

Conclusions:

  • RHD causes substantial premature mortality and elevated death rates in Kimberley's Aboriginal population, aligning with trends in northern Australia.
  • The WA RHD Program aims to reduce RHD mortality and morbidity.
  • Further research and investment are crucial to address RHD, a disease linked to socioeconomic disadvantage.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
543
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
484
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
929